Chemotherapy risk study for older adults with cancer
Part of Cancer clinical trials.
This study looks at older adults (70+) with solid tumors who are starting or changing chemotherapy. It aims to understand how likely side effects are and help doctors personalize care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 70 years old or older.
- You have a solid tumor cancer (any stage).
- You are able to walk and take care of yourself (ECOG score 0–2).
- You are about to start a new chemotherapy treatment (or switch to a new chemo regimen).
- You can read and write, or communicate in Chinese.
- You are not on immunotherapy or targeted therapy alone (must have chemo).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a program designed to help older adults with cancer who are starting a new chemotherapy or immune therapy. The program uses an electronic frailty score to provide extra support and resources to improve your overall well-being during treatment.
This study looks at young people (40 or younger at diagnosis) with solid tumors in China. It aims to collect real-world information about their treatments and outcomes to find patterns that could help improve care.
This study tracks the heart health of adults receiving chemotherapy that may affect the heart. It helps doctors understand how to better monitor and protect patients.
This trial tests whether a special geriatric assessment can help manage side effects for adults aged 60 and older with non-small cell lung cancer who are starting a new treatment plan that includes chemotherapy and radiation. It aims to improve quality of life and treatment outcomes.
This study looks at how chemotherapy and immunotherapy affect the body in older adults with colorectal cancer, especially early side effects. It may help researchers understand why some people lose strength and how to better predict and manage treatment toxicity.
This trial looks at differences between younger and older breast cancer patients to better understand the disease. If you had breast cancer between the ages of 18 and 75 and were treated in a Chinese hospital from 2000 to 2024, you might be able to help.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.